Efficacy of Intramuscular Naloxone 0.4mg. in Prophylaxis of Intrathecal Morphine Induced Pruritus After Cesarean Section
NCT ID: NCT00890942
Last Updated: 2011-07-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2009-05-31
2010-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Epidural Nalbuphine for Postcesarean Epidural Morphine Induced Pruritus
NCT00707824
Comparison of Surgical Rectus Sheath Block and Intrathecal Morphine
NCT02790099
Propofol for Prophylaxis of Morphine Induced Pruritis in Caesarean Section
NCT06188546
Intrathecal Dexamethasone and Labor Analgesia
NCT02588417
Local Lidocaine Infiltration for Pain Management Post Cesarean Delivery.
NCT00737542
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
naloxone
naloxone
naloxone 0.4mg.(1 ml) intramuscular
normal saline
normal saline
normal saline 1 ml IM
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
naloxone
naloxone 0.4mg.(1 ml) intramuscular
normal saline
normal saline 1 ml IM
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* complicated pregnancy
* have history of drug abuse during pregnancy
* obesity BMI\>35kg./m2
18 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mahidol University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mahidol University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tachawan Jirativanont, MD
Role: PRINCIPAL_INVESTIGATOR
Anesthesiology department ,Siriraj hopital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Anesthesiology department, Siriraj Hospital, Mahidol University
Bangkok, , Thailand
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Si146/2009
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.